UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025778 |
|---|---|
| Receipt number | R000029555 |
| Scientific Title | Prospective cohort study of corticosteroids for inflammatory bowel disease |
| Date of disclosure of the study information | 2017/01/22 |
| Last modified on | 2018/07/31 19:26:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prospective cohort study of corticosteroids for inflammatory bowel disease
Acronym
Prospective cohort study of corticosteroids for inflammatory bowel disease
Scientific Title
Prospective cohort study of corticosteroids for inflammatory bowel disease
Scientific Title:Acronym
Prospective cohort study of corticosteroids for inflammatory bowel disease
Region
| Japan |
Condition
Condition
Inflammatory bowel disease
Classification by specialty
| Gastroenterology | Hepato-biliary-pancreatic medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate effectiveness evaluation of PSL for inflammatory bowel disease
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Response rates of 8 weeks after corticosteroids
Key secondary outcomes
Response rates at 30 weeks and 54 weeks after corticosteroids
Remission rates at 8, 30 weeks and 54 weeks after corticosteroids
The incidence of adverse events
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1)patients of ulcerative colitis or Crohn disease
2)Partial Mayo score above2 or CDAI above149
3)with agreement
Key exclusion criteria
1)colitis other than ulcerative colitis or Crohn disease
2)patients who have symptomatic gastrointestinal stenosis
3)patients who destine to undergo colectomy
4)serious infectious disease
5)patients who investigators and subinvestigators consider to be inappropriate to participate in this study
Target sample size
600
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Makoto Naganuma |
Organization
Keio University
Division name
Gastroenterology and Hepatology
Zip code
Address
35 Shinano-machi, Shinjyu-ku , Tokyo
TEL
03-3353-1211
nagamakoto@z7.keio.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Makoto Mutaguchi |
Organization
Keio University
Division name
Gastroenterology and Hepatology
Zip code
Address
35 Shinano-machi, Shinjyu-ku , Tokyo
TEL
03-3353-1211
Homepage URL
m.mutaguchi@keio.jp
Sponsor or person
Institute
Keio University Gastroenterology and Hepatology
Institute
Department
Personal name
Funding Source
Organization
self funing
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 01 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2016 | Year | 11 | Month | 10 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 01 | Month | 22 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Prospective cohort study
Management information
Registered date
| 2017 | Year | 01 | Month | 20 | Day |
Last modified on
| 2018 | Year | 07 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029555
